Study of NGM438 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumors
- Carcinoma
- Carcinoma, Renal Cell
- Mesothelioma
- Cholangiocarcinoma
- Squamous Cell Carcinoma of Head and Neck
Age: 18 years - 66+
Gender: All
We've found 3 total result s for "Mesothelioma".
Study of NGM438 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumors
Age: 18 years - 66+
Gender: All
This study will examine the safety and potential effectiveness of poly-ICLC directly injected into malignant pleural mesothelioma at the time of biopsy up to 21 days prior to the cancer being removed by the surgeon
Age: Birth - 66+
Gender: All
This trial studies how well the addition of targeted radiation therapy to surgery and the usual chemotherapy treatment works for the treatment of stage I-IIIA malignant pleural mesothelioma. Targeted radiation therapy such as intensity-modulated radiation therapy or...
Age: 18 - 80 years
Gender: All